PetMed Express Inc (PETS): Revenue

Annual figures by period end, from SEC filings.

$179.02M

Year ended 2026-03-31

$168.86M

Trailing 12 months to 2026-06-30

-10.2%

3-year compound annual growth

2023-03-31 Revenue (USD) 2026-03-31

Period ended	Revenue	Change YoY	Source filing
2026-03-31	$179.02M	-21.1%	2026-06-02, From 2025-04-01
2025-03-31	$226.97M	-17.2%	2026-06-02, From 2024-04-01
2024-03-31	$274.10M	+10.7%	2026-06-02, From 2023-04-01
2023-03-31	$247.57M	n/a	2025-10-14, From 2022-04-01

Revenue at similar companies

Companies with the same SEC industry code (Retail-Drug Stores and Proprietary Stores), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Revenue	Change YoY
PetMed Express Inc (PETS)	2026-03-31	$179.02M	-21.1%
Ridgetech Inc. (RDGT)	2026-03-31	$132.16M	+10.2%
Guardian Pharmacy Services, Inc. (GRDN)	2025-12-31	$1.45B	+17.9%
CVS Health Corp (CVS)	2025-12-31	$402.07B	+7.8%

Compare PETS, RDGT, GRDN, CVS side by side · Screen every company in Retail-Drug Stores and Proprietary Stores ↗